{"nct_id":"NCT05200364","title":"A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer","status":"TERMINATED","status_verified_date":"2024-11","start_date":"2022-03-22","start_date_type":"ACTUAL","primary_completion_date":"2025-06-01","primary_completion_date_type":"ACTUAL","completion_date":"2025-06-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["STRO"]}